Dairy Product Intake and Risk of Type 2 Diabetes in EPIC-InterAct: A Mendelian Randomization Study.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
04 2019
Historique:
received: 26 09 2018
accepted: 09 01 2019
pubmed: 8 2 2019
medline: 25 12 2019
entrez: 8 2 2019
Statut: ppublish

Résumé

To estimate the causal association between intake of dairy products and incident type 2 diabetes. The analysis included 21,820 European individuals (9,686 diabetes cases) of the European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study. Participants were genotyped, and rs4988235 (LCT-12910C>T), a single nucleotide polymorphism (SNP) for lactase persistence (LP) that enables digestion of dairy sugar, i.e., lactose, was imputed. Baseline dietary intakes were assessed with diet questionnaires. We investigated the associations between imputed SNP dosage for rs4988235 and intake of dairy products and other foods through linear regression. Mendelian randomization (MR) estimates for the milk-diabetes relationship were obtained through a two-stage least squares regression. Each additional LP allele was associated with a higher intake of milk (β 17.1 g/day, 95% CI 10.6-23.6) and milk beverages (β 2.8 g/day, 95% CI 1.0-4.5) but not with intake of other dairy products. Other dietary intakes associated with rs4988235 included fruits (β -7.0 g/day, 95% CI -12.4 to -1.7 per additional LP allele), nonalcoholic beverages (β -18.0 g/day, 95% CI -34.4 to -1.6), and wine (β -4.8 g/day, 95% CI -9.1 to -0.6). In instrumental variable analysis, LP-associated milk intake was not associated with diabetes (hazard ratio rs4988235 was associated with milk intake but not with intake of other dairy products. This MR study does not suggest that milk intake is associated with diabetes, which is consistent with previous observational and genetic associations. LP may be associated with intake of other foods as well, but owing to the modest associations, we consider it unlikely that this caused the observed null result.

Identifiants

pubmed: 30728219
pii: dc18-2034
doi: 10.2337/dc18-2034
pmc: PMC7340535
mid: EMS86548
doi:

Substances chimiques

Lactase EC 3.2.1.108

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

568-575

Subventions

Organisme : Wellcome Trust
ID : LEAP 205212/Z/16/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00002/7
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204623/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/5
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/13/33946
Pays : United Kingdom

Informations de copyright

© 2019 by the American Diabetes Association.

Références

Adv Nutr. 2011 Sep;2(5):396-407
pubmed: 22332081
Int J Epidemiol. 1997;26 Suppl 1:S1-5
pubmed: 9126528
Int J Epidemiol. 1997;26 Suppl 1:S37-48
pubmed: 9126532
BMC Evol Biol. 2010 Feb 09;10:36
pubmed: 20144208
Int J Epidemiol. 1997;26 Suppl 1:S152-60
pubmed: 9126543
Nat Genet. 2013 Nov;45(11):1274-1283
pubmed: 24097068
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Public Health Nutr. 2003 Jun;6(4):407-13
pubmed: 12795830
Nat Rev Cardiol. 2017 Oct;14(10):577-590
pubmed: 28569269
Int J Epidemiol. 2015 Apr;44(2):496-511
pubmed: 25953784
Public Health Nutr. 2002 Dec;5(6B):1259-71
pubmed: 12639231
Nat Genet. 2014 Nov;46(11):1173-86
pubmed: 25282103
Am J Clin Nutr. 2012 Aug;96(2):382-90
pubmed: 22760573
Nature. 2015 Feb 12;518(7538):187-196
pubmed: 25673412
Int J Epidemiol. 2004 Feb;33(1):30-42
pubmed: 15075143
Diabetes Care. 2002 Jan;25(1):148-98
pubmed: 11772915
Am J Epidemiol. 2009 Feb 15;169(4):505-14
pubmed: 19126586
PLoS Med. 2014 May 20;11(5):e1001647
pubmed: 24845081
Int J Epidemiol. 2011 Jun;40(3):755-64
pubmed: 21414999
Am J Clin Nutr. 1999 Oct;70(4):439-47
pubmed: 10500011
Int J Cancer. 2013 Apr 15;132(8):1901-10
pubmed: 22965418
Hum Mol Genet. 2014 Sep 15;23(R1):R89-98
pubmed: 25064373
Am J Clin Nutr. 2016 Apr;103(4):1111-24
pubmed: 26912494
Bioinformatics. 2016 Oct 15;32(20):3207-3209
pubmed: 27318201
Eur J Clin Nutr. 2017 Aug;71(8):1008-1012
pubmed: 28225053
Lancet Diabetes Endocrinol. 2014 Oct;2(10):810-8
pubmed: 25107467
Nat Rev Genet. 2010 Jul;11(7):499-511
pubmed: 20517342
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):956-61
pubmed: 17507622
Nat Genet. 2014 Mar;46(3):234-44
pubmed: 24509480
Metabolism. 2013 Sep;62(9):1323-9
pubmed: 23647908
Obesity (Silver Spring). 2011 Aug;19(8):1707-14
pubmed: 21193851
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Am J Clin Nutr. 2015 Aug;102(2):487-96
pubmed: 26156736
Nat Genet. 2002 Feb;30(2):233-7
pubmed: 11788828
Eur J Clin Nutr. 2004 Sep;58(9):1319-22
pubmed: 15054412
Curr Opin Lipidol. 2017 Feb;28(1):46-51
pubmed: 27906713
Eur J Hum Genet. 2009 Mar;17(3):357-67
pubmed: 18797476
Am J Clin Nutr. 2017 May;105(5):1033-1045
pubmed: 28404576

Auteurs

Linda E T Vissers (LET)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Ivonne Sluijs (I)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands i.sluijs-2@umcutrecht.nl.

Yvonne T van der Schouw (YT)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Nita G Forouhi (NG)

MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.

Fumiaki Imamura (F)

MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.

Stephen Burgess (S)

Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, U.K.

Aurelio Barricarte (A)

Navarre Public Health Institute (ISPN), Pamplona, Spain.

Heiner Boeing (H)

German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

Catalina Bonet (C)

Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia, Barcelona, Spain.

Maria-Dolores Chirlaque (MD)

Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, University of Murcia, Murcia, Spain.
CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.

Guy Fagherazzi (G)

Centre for Research in Epidemiology and Population Health (CESP), UMR1018, INSERM, Institut Gustave Roussy, Paris South University-Paris-Saclay University, Villejuif, France.

Paul W Franks (PW)

Lund University, Malmö, Sweden.

Heinz Freisling (H)

Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.

Marc J Gunter (MJ)

Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.

J Ramón Quirós (JR)

Public Health Directorate, Asturias, Spain.

Daniel B Ibsen (DB)

Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.

Rudolf Kaaks (R)

German Cancer Research Center (DKFZ), Heidelberg, Germany.

Timothy Key (T)

University of Oxford, Oxford, U.K.

Kay T Khaw (KT)

Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, U.K.

Tilman Kühn (T)

German Cancer Research Center (DKFZ), Heidelberg, Germany.

Olatz Mokoroa (O)

CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Public Health Division of Gipuzkoa, Biodonostia Research Institute, San Sebastian, Spain.

Peter M Nilsson (PM)

Lund University, Malmö, Sweden.

Kim Overvad (K)

Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.

Valeria Pala (V)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Domenico Palli (D)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Salvatore Panico (S)

Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, University Hospital "Città della Salute e della Scienza," University of Turin, and Center for Cancer Prevention (CPO), Torino, Italy.

Annemieke M W Spijkerman (AMW)

National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

Anne Tjonneland (A)

Danish Cancer Society Research Center, Copenhagen, Denmark.

Rosario Tumino (R)

Azienda Sanitaria Provinciale (ASP) Ragusa, Ragusa, Italy.

Miguel Rodríguez-Barranco (M)

CIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada, Universidad de Granada, Granada, Spain.

Olov Rolandsson (O)

Umeå University, Umeå, Sweden.

Elio Riboli (E)

School of Public Health, Imperial College London, London, U.K.

Stephen J Sharp (SJ)

MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.

Claudia Langenberg (C)

MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.

Nicholas J Wareham (NJ)

MRC Epidemiology Unit, University of Cambridge, Cambridge, U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH